Big data powers design of ‘smart’ cell therapies for cancer
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy…
Browsing: CAR-T Therapy
ASTRO 2020: Study supports use of radiation before CAR therapy for multiple myeloma
Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured…
Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and…
Treatment shows promise in treating deadly brain cancer
Researchers of McMaster University and the University of Toronto, Canada, have developed a promising immunotherapy…
New study finds cellular immunotherapy treatment associated with improved quality of life
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy…
Building a safer CAR-T therapy
A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
New CAR T case study shows promise in acute myeloid leukaemia
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest…
Cancer killing clue could lead to safer and more powerful immunotherapies
New research could help to safely adapt a new immunotherapy – currently only effective in…